Global Tildrakizumab Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Tildrakizumab market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
The Global Info Research report includes an overview of the development of the Tildrakizumab industry chain, the market status of Hospital (18MIU /Vial, 25MIU /Vial), Drug Store (18MIU /Vial, 25MIU /Vial), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Tildrakizumab.
Regionally, the report analyzes the Tildrakizumab markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Tildrakizumab market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Tildrakizumab market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Tildrakizumab industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 18MIU /Vial, 25MIU /Vial).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Tildrakizumab market.
Regional Analysis: The report involves examining the Tildrakizumab market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Tildrakizumab market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Tildrakizumab:
Company Analysis: Report covers individual Tildrakizumab manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Tildrakizumab This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug Store).
Technology Analysis: Report covers specific technologies relevant to Tildrakizumab. It assesses the current state, advancements, and potential future developments in Tildrakizumab areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Tildrakizumab market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Tildrakizumab market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Tildrakizumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tildrakizumab, with price, sales, revenue and global market share of Tildrakizumab from 2019 to 2024.
Chapter 3, the Tildrakizumab competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tildrakizumab breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Tildrakizumab market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tildrakizumab.
Chapter 14 and 15, to describe Tildrakizumab sales channel, distributors, customers, research findings and conclusion.
Tildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoriasis.
The Global Info Research report includes an overview of the development of the Tildrakizumab industry chain, the market status of Hospital (18MIU /Vial, 25MIU /Vial), Drug Store (18MIU /Vial, 25MIU /Vial), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Tildrakizumab.
Regionally, the report analyzes the Tildrakizumab markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Tildrakizumab market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Tildrakizumab market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Tildrakizumab industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 18MIU /Vial, 25MIU /Vial).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Tildrakizumab market.
Regional Analysis: The report involves examining the Tildrakizumab market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Tildrakizumab market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Tildrakizumab:
Company Analysis: Report covers individual Tildrakizumab manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Tildrakizumab This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drug Store).
Technology Analysis: Report covers specific technologies relevant to Tildrakizumab. It assesses the current state, advancements, and potential future developments in Tildrakizumab areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Tildrakizumab market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Tildrakizumab market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- 18MIU /Vial
- 25MIU /Vial
- Hospital
- Drug Store
- Sun Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Tildrakizumab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tildrakizumab, with price, sales, revenue and global market share of Tildrakizumab from 2019 to 2024.
Chapter 3, the Tildrakizumab competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tildrakizumab breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Tildrakizumab market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tildrakizumab.
Chapter 14 and 15, to describe Tildrakizumab sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Tildrakizumab
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tildrakizumab Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 18MIU /Vial
1.3.3 25MIU /Vial
1.4 Market Analysis by Application
1.4.1 Overview: Global Tildrakizumab Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Drug Store
1.5 Global Tildrakizumab Market Size & Forecast
1.5.1 Global Tildrakizumab Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Tildrakizumab Sales Quantity (2019-2030)
1.5.3 Global Tildrakizumab Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sun Pharma
2.1.1 Sun Pharma Details
2.1.2 Sun Pharma Major Business
2.1.3 Sun Pharma Tildrakizumab Product and Services
2.1.4 Sun Pharma Tildrakizumab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sun Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TILDRAKIZUMAB BY MANUFACTURER
3.1 Global Tildrakizumab Sales Quantity by Manufacturer (2019-2024)
3.2 Global Tildrakizumab Revenue by Manufacturer (2019-2024)
3.3 Global Tildrakizumab Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Tildrakizumab by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Tildrakizumab Manufacturer Market Share in 2023
3.4.2 Top 6 Tildrakizumab Manufacturer Market Share in 2023
3.5 Tildrakizumab Market: Overall Company Footprint Analysis
3.5.1 Tildrakizumab Market: Region Footprint
3.5.2 Tildrakizumab Market: Company Product Type Footprint
3.5.3 Tildrakizumab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Tildrakizumab Market Size by Region
4.1.1 Global Tildrakizumab Sales Quantity by Region (2019-2030)
4.1.2 Global Tildrakizumab Consumption Value by Region (2019-2030)
4.1.3 Global Tildrakizumab Average Price by Region (2019-2030)
4.2 North America Tildrakizumab Consumption Value (2019-2030)
4.3 Europe Tildrakizumab Consumption Value (2019-2030)
4.4 Asia-Pacific Tildrakizumab Consumption Value (2019-2030)
4.5 South America Tildrakizumab Consumption Value (2019-2030)
4.6 Middle East and Africa Tildrakizumab Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Tildrakizumab Sales Quantity by Type (2019-2030)
5.2 Global Tildrakizumab Consumption Value by Type (2019-2030)
5.3 Global Tildrakizumab Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Tildrakizumab Sales Quantity by Application (2019-2030)
6.2 Global Tildrakizumab Consumption Value by Application (2019-2030)
6.3 Global Tildrakizumab Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Tildrakizumab Sales Quantity by Type (2019-2030)
7.2 North America Tildrakizumab Sales Quantity by Application (2019-2030)
7.3 North America Tildrakizumab Market Size by Country
7.3.1 North America Tildrakizumab Sales Quantity by Country (2019-2030)
7.3.2 North America Tildrakizumab Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Tildrakizumab Sales Quantity by Type (2019-2030)
8.2 Europe Tildrakizumab Sales Quantity by Application (2019-2030)
8.3 Europe Tildrakizumab Market Size by Country
8.3.1 Europe Tildrakizumab Sales Quantity by Country (2019-2030)
8.3.2 Europe Tildrakizumab Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Tildrakizumab Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Tildrakizumab Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Tildrakizumab Market Size by Region
9.3.1 Asia-Pacific Tildrakizumab Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Tildrakizumab Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Tildrakizumab Sales Quantity by Type (2019-2030)
10.2 South America Tildrakizumab Sales Quantity by Application (2019-2030)
10.3 South America Tildrakizumab Market Size by Country
10.3.1 South America Tildrakizumab Sales Quantity by Country (2019-2030)
10.3.2 South America Tildrakizumab Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tildrakizumab Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Tildrakizumab Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Tildrakizumab Market Size by Country
11.3.1 Middle East & Africa Tildrakizumab Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Tildrakizumab Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Tildrakizumab Market Drivers
12.2 Tildrakizumab Market Restraints
12.3 Tildrakizumab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Tildrakizumab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tildrakizumab
13.3 Tildrakizumab Production Process
13.4 Tildrakizumab Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tildrakizumab Typical Distributors
14.3 Tildrakizumab Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Tildrakizumab Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Tildrakizumab Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Sun Pharma Major Business
Table 5. Sun Pharma Tildrakizumab Product and Services
Table 6. Sun Pharma Tildrakizumab Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sun Pharma Recent Developments/Updates
Table 8. Global Tildrakizumab Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 9. Global Tildrakizumab Revenue by Manufacturer (2019-2024) & (USD Million)
Table 10. Global Tildrakizumab Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 11. Market Position of Manufacturers in Tildrakizumab, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 12. Head Office and Tildrakizumab Production Site of Key Manufacturer
Table 13. Tildrakizumab Market: Company Product Type Footprint
Table 14. Tildrakizumab Market: Company Product Application Footprint
Table 15. Tildrakizumab New Market Entrants and Barriers to Market Entry
Table 16. Tildrakizumab Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 18. Global Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 19. Global Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 20. Global Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 21. Global Tildrakizumab Average Price by Region (2019-2024) & (USD/Unit)
Table 22. Global Tildrakizumab Average Price by Region (2025-2030) & (USD/Unit)
Table 23. Global Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 24. Global Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 25. Global Tildrakizumab Consumption Value by Type (2019-2024) & (USD Million)
Table 26. Global Tildrakizumab Consumption Value by Type (2025-2030) & (USD Million)
Table 27. Global Tildrakizumab Average Price by Type (2019-2024) & (USD/Unit)
Table 28. Global Tildrakizumab Average Price by Type (2025-2030) & (USD/Unit)
Table 29. Global Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 30. Global Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 31. Global Tildrakizumab Consumption Value by Application (2019-2024) & (USD Million)
Table 32. Global Tildrakizumab Consumption Value by Application (2025-2030) & (USD Million)
Table 33. Global Tildrakizumab Average Price by Application (2019-2024) & (USD/Unit)
Table 34. Global Tildrakizumab Average Price by Application (2025-2030) & (USD/Unit)
Table 35. North America Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 36. North America Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 37. North America Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 38. North America Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 39. North America Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 40. North America Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 41. North America Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 42. North America Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 43. Europe Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Europe Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Europe Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 46. Europe Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 47. Europe Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 48. Europe Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 49. Europe Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 52. Asia-Pacific Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 53. Asia-Pacific Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 54. Asia-Pacific Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 55. Asia-Pacific Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 56. Asia-Pacific Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 57. Asia-Pacific Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 58. Asia-Pacific Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 59. South America Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 60. South America Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 61. South America Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 62. South America Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 63. South America Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 64. South America Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 65. South America Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 66. South America Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Middle East & Africa Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 68. Middle East & Africa Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 69. Middle East & Africa Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Middle East & Africa Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Middle East & Africa Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 72. Middle East & Africa Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 73. Middle East & Africa Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Middle East & Africa Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 75. Tildrakizumab Raw Material
Table 76. Key Manufacturers of Tildrakizumab Raw Materials
Table 77. Tildrakizumab Typical Distributors
Table 78. Tildrakizumab Typical Customers
Table 1. Global Tildrakizumab Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Tildrakizumab Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Sun Pharma Major Business
Table 5. Sun Pharma Tildrakizumab Product and Services
Table 6. Sun Pharma Tildrakizumab Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sun Pharma Recent Developments/Updates
Table 8. Global Tildrakizumab Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 9. Global Tildrakizumab Revenue by Manufacturer (2019-2024) & (USD Million)
Table 10. Global Tildrakizumab Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 11. Market Position of Manufacturers in Tildrakizumab, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 12. Head Office and Tildrakizumab Production Site of Key Manufacturer
Table 13. Tildrakizumab Market: Company Product Type Footprint
Table 14. Tildrakizumab Market: Company Product Application Footprint
Table 15. Tildrakizumab New Market Entrants and Barriers to Market Entry
Table 16. Tildrakizumab Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 18. Global Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 19. Global Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 20. Global Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 21. Global Tildrakizumab Average Price by Region (2019-2024) & (USD/Unit)
Table 22. Global Tildrakizumab Average Price by Region (2025-2030) & (USD/Unit)
Table 23. Global Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 24. Global Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 25. Global Tildrakizumab Consumption Value by Type (2019-2024) & (USD Million)
Table 26. Global Tildrakizumab Consumption Value by Type (2025-2030) & (USD Million)
Table 27. Global Tildrakizumab Average Price by Type (2019-2024) & (USD/Unit)
Table 28. Global Tildrakizumab Average Price by Type (2025-2030) & (USD/Unit)
Table 29. Global Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 30. Global Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 31. Global Tildrakizumab Consumption Value by Application (2019-2024) & (USD Million)
Table 32. Global Tildrakizumab Consumption Value by Application (2025-2030) & (USD Million)
Table 33. Global Tildrakizumab Average Price by Application (2019-2024) & (USD/Unit)
Table 34. Global Tildrakizumab Average Price by Application (2025-2030) & (USD/Unit)
Table 35. North America Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 36. North America Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 37. North America Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 38. North America Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 39. North America Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 40. North America Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 41. North America Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 42. North America Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 43. Europe Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 44. Europe Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 45. Europe Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 46. Europe Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 47. Europe Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 48. Europe Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 49. Europe Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 50. Europe Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 51. Asia-Pacific Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 52. Asia-Pacific Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 53. Asia-Pacific Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 54. Asia-Pacific Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 55. Asia-Pacific Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 56. Asia-Pacific Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 57. Asia-Pacific Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 58. Asia-Pacific Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 59. South America Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 60. South America Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 61. South America Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 62. South America Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 63. South America Tildrakizumab Sales Quantity by Country (2019-2024) & (K Units)
Table 64. South America Tildrakizumab Sales Quantity by Country (2025-2030) & (K Units)
Table 65. South America Tildrakizumab Consumption Value by Country (2019-2024) & (USD Million)
Table 66. South America Tildrakizumab Consumption Value by Country (2025-2030) & (USD Million)
Table 67. Middle East & Africa Tildrakizumab Sales Quantity by Type (2019-2024) & (K Units)
Table 68. Middle East & Africa Tildrakizumab Sales Quantity by Type (2025-2030) & (K Units)
Table 69. Middle East & Africa Tildrakizumab Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Middle East & Africa Tildrakizumab Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Middle East & Africa Tildrakizumab Sales Quantity by Region (2019-2024) & (K Units)
Table 72. Middle East & Africa Tildrakizumab Sales Quantity by Region (2025-2030) & (K Units)
Table 73. Middle East & Africa Tildrakizumab Consumption Value by Region (2019-2024) & (USD Million)
Table 74. Middle East & Africa Tildrakizumab Consumption Value by Region (2025-2030) & (USD Million)
Table 75. Tildrakizumab Raw Material
Table 76. Key Manufacturers of Tildrakizumab Raw Materials
Table 77. Tildrakizumab Typical Distributors
Table 78. Tildrakizumab Typical Customers
LIST OF FIGURES
Figure 1. Tildrakizumab Picture
Figure 2. Global Tildrakizumab Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Tildrakizumab Consumption Value Market Share by Type in 2023
Figure 4. 18MIU /Vial Examples
Figure 5. 25MIU /Vial Examples
Figure 6. Global Tildrakizumab Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Tildrakizumab Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Global Tildrakizumab Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Tildrakizumab Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Tildrakizumab Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Tildrakizumab Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Tildrakizumab Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Tildrakizumab Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Tildrakizumab by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Tildrakizumab Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Tildrakizumab Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Tildrakizumab Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Tildrakizumab Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Tildrakizumab Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Tildrakizumab Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 52. China Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Tildrakizumab Market Drivers
Figure 73. Tildrakizumab Market Restraints
Figure 74. Tildrakizumab Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Tildrakizumab in 2023
Figure 77. Manufacturing Process Analysis of Tildrakizumab
Figure 78. Tildrakizumab Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Tildrakizumab Picture
Figure 2. Global Tildrakizumab Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Tildrakizumab Consumption Value Market Share by Type in 2023
Figure 4. 18MIU /Vial Examples
Figure 5. 25MIU /Vial Examples
Figure 6. Global Tildrakizumab Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Tildrakizumab Consumption Value Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Global Tildrakizumab Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Tildrakizumab Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Tildrakizumab Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Tildrakizumab Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Tildrakizumab Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Tildrakizumab Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Tildrakizumab by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Tildrakizumab Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Tildrakizumab Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Tildrakizumab Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Tildrakizumab Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Tildrakizumab Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Tildrakizumab Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Tildrakizumab Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 52. China Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Tildrakizumab Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Tildrakizumab Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Tildrakizumab Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Tildrakizumab Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Tildrakizumab Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Tildrakizumab Market Drivers
Figure 73. Tildrakizumab Market Restraints
Figure 74. Tildrakizumab Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Tildrakizumab in 2023
Figure 77. Manufacturing Process Analysis of Tildrakizumab
Figure 78. Tildrakizumab Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
